Showing results (1041-1050 of 1,127) with videos related to
Sort By:
Pageof 113
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritisM Kloppenburg, E Maheu, V B Kraus, et al.European Radiology Experimental|July 26, 2024
Development of an initial training and evaluation programme for manual lower limb muscle MRI segmentationJasper M Morrow, Sachit Shah, Lara Cristiano, et al.ACS Applied Materials & Interfaces|September 25, 2024
Elucidating the Molecular Mechanisms by which Porous Polymer Networks Affect Structure, Aging Propensity, and Selectivity of Microporous Glassy Polymer Membranes using a Multiscale ApproachLucas C Condes, Matthew T Webb, Tran T B Le, et al.Rheumatology (Oxford, England)|September 9, 2004
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensusE Roddy, W Zhang, M Doherty, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.Annals of the Rheumatic Diseases|September 19, 2009
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritisW Zhang, M Doherty, G Peat, et al.The Journal of Pharmacology and Experimental Therapeutics|December 24, 2004
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic propertiesNarender R Gavva, Rami Tamir, Yusheng Qu, et al.Journal of Medicinal Chemistry|June 26, 2007
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamidesMark H Norman, Jiawang Zhu, Christopher Fotsch, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.Annals of the Rheumatic Diseases|May 19, 2006
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)W Zhang, M Doherty, E Pascual, et al.Pageof 113